Results 11 to 20 of about 54,247 (284)

Omnipod® Insulin Management System - "patch-pump", as a breakthrough in the treatment of type 1 diabetes

open access: yesJournal of Education, Health and Sport, 2022
Introduction: There are 425 million adults with diabetes worldwide, 10% of whom have type 1 diabetes. The treatment of choice in this group of patients is insulin delivery. In order to avoid disease-related metabolic disorders, insulin therapy should be
Joanna Filipczak   +10 more
doaj   +1 more source

A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data. [PDF]

open access: yes, 2015
BackgroundIn type 1 diabetes (T1D), periodic review of blood glucose and insulin dosing should be performed, but it is not known how often patients review these data on their own.
Adi, Saleh   +3 more
core   +1 more source

Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes

open access: yesEndocrine Connections, 2023
Diabetes technology continues to advance, with more individuals with type 1 diabetes (T1D) adopting insulin pumps, continuous glucose monitoring (CGM), and automated insulin delivery (AID) systems that integrate real-time glucose data with an algorithm ...
Molly L Tanenbaum, Persis V Commissariat
doaj   +1 more source

Association Between Perceived Health Care Provider Support and Satisfaction with Insulin Pumps in Children with Type 1 Diabetes Mellitus: Opportunities for Pharmacists

open access: yesINNOVATIONS in Pharmacy, 2015
Purpose: The purpose of this pilot study was to describe parents’ perceived healthcare provider support for integrating technology, satisfaction with insulin pump use in their child with T1DM, and the relationship between parents’ perceived healthcare ...
Laura Brooke Jowers   +3 more
doaj   +1 more source

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes

open access: yesFrontiers in Endocrinology, 2023
ObjectiveCystic fibrosis (CF)-related diabetes (CFRD) resulting from partial-to-complete insulin deficiency occurs in 40-50% of adults with CF.
V. Grancini   +14 more
doaj   +1 more source

Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis

open access: yesSystematic Reviews, 2020
Background With the rapid development of technologies for type 1 diabetes, economic evaluations are integral in guiding cost-effective clinical and policy decisions.
Anthony Pease   +5 more
doaj   +1 more source

Case Law: A Review of Selected Pharmaceutical Patents in the UK Courts during 2021

open access: yesBritish Journal of Pharmacy, 2022
Patents lie at the interface between technology and law. This review provides a summary of four high-profile cases from 2021 in which patents in the pharmaceutical or medical space were litigated in the UK Courts.
Sarah-Jane Crawford   +2 more
doaj   +1 more source

Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023

open access: yesLife, 2023
Type 1 diabetes (T1D) patients’ lifestyle and prognosis has remarkably changed over the years, especially after the introduction of insulin pumps, in particular advanced hybrid closed loop systems (AHCL).
Marta Bassi   +10 more
doaj   +1 more source

Hypothalamic Vitamin D Improves Glucose Homeostasis and Reduces Weight [PDF]

open access: yes, 2016
Despite clear associations between vitamin D deficiency and obesity and/or type 2 diabetes, a causal relationship is not established. Vitamin D receptors (VDRs) are found within multiple tissues, including the brain.
Arble, Deanna M.   +9 more
core   +4 more sources

Home - About - Disclaimer - Privacy